Key result
A physician-pharmacist cooperation program did not significantly improve home morning BP control (53% vs 47%, P=0.40), but significantly reduced diastolic BP and antihypertensive medication use.
Why the study?
Does a physician-pharmacist cooperation program improve blood pressure control and cardiovascular risk factors in patients with mild to moderate hypertension?
Population
132 subjects aged 40-79 years with mild to moderate hypertension, either treatment-naive or on medication.
Comparison
Physician-pharmacist cooperation program vs Control group
Design
RCT, Equal numbers of subjects were randomly assigned to one of two groups
Follow-up
6 months
Authors
Loading...
Physician-pharmacist program fails primary morning BP control endpoint; leaves open diastolic and medication-reduction benefits for further study.
RCT (n=132)
Does a physician-pharmacist cooperation program improve blood pressure control and cardiovascular risk factors in patients with mild to moderate hypertension?
Absolute Event Rate: 53% vs 47%
p-value: p=0.40
A physician-pharmacist cooperation program significantly improves diastolic blood pressure control and facilitates the reduction of antihypertensive medication use in patients with mild to moderate hypertension.
Tobari et al. (2010) conducted an RCT in Mild to moderate hypertension (n=132). Physician-pharmacist cooperation program vs. Control group was evaluated on Control of home morning blood pressure (p=0.40). A physician-pharmacist cooperation program did not significantly improve home morning BP control (53% vs 47%, P=0.40), but significantly reduced diastolic BP and antihypertensive medication use.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: